Pepticker
§ Same category · GLP-1 / metabolic peptides

Retatrutide vs Survodutide

Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.

Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.

Retatrutide
14
vendors tracked
from $2.90/mg
Survodutide
3
vendors tracked
from $7.80/mg
◎ Cheapest $/mg:Retatrutide at $2.90/mg

Retatrutide

Triple GCG/GIP/GLP-1 agonist

Operational
$29.00
$2.90/mg
In stockOn sale
Buy with code →
Operational
$54.50
$5.45/mg
In stock87.9% vs best
Visit →
Operational
$78.00
$7.80/mg
Out of stock169.0% vs best
Visit →
Operational
$79.00
$7.90/mg
In stock172.4% vs best
Visit →
Operational
$93.49
$9.35/mg
In stockOn sale222.4% vs best
Visit →
$103.99
$10.40/mg
In stock258.6% vs best
Visit →
Operational
$107.25
$10.72/mg
In stock269.8% vs best
Visit →
Operational
$109.00
$10.90/mg
In stock275.9% vs best
Visit →
$109.00
$10.90/mg
In stock275.9% vs best
Visit →
$129.99
$13.00/mg
Out of stock348.2% vs best
Visit →
$134.99
$13.50/mg
In stock365.5% vs best
Visit →
Sort:
2026-05-09

Survodutide

Glucagon/GLP-1 dual agonist

Operational
$78.00
$7.80/mg
In stock◎ Best $/mg
Buy with code →
$95.00
$9.50/mg
In stock21.8% vs best
Visit →
Sort:
2026-05-09

About Retatrutide

An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.

About Survodutide

A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.